Dentsply International (XRAY) reported $936 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.9%. EPS of $0.52 for the same period compares to $0.49 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $933.1 million, representing a surprise of +0.31%. The company delivered an EPS surprise of +4%, with the consensus EPS estimate being $0.50.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Organic sales growth: -4.9% compared to the -4.6% average estimate based on six analysts.
- Revenues- United States: $293 million compared to the $323.26 million average estimate based on three analysts.
- Revenues- Rest of World: $239 million versus the three-analyst average estimate of $222.59 million. The reported number represents a year-over-year change of +0.8%.
- Revenues- Europe: $404 million versus $389.9 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +4.4% change.
- Net sales- Connected Technology Solutions: $243 million versus $251.55 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -4% change.
- Net sales- Wellspect Healthcare: $80 million versus $81.45 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a 0% change.
- Net sales- Essential Dental Solutions: $387 million compared to the $373.62 million average estimate based on five analysts. The reported number represents a change of +3.2% year over year.
- Net sales- Orthodontic and Implant Solutions: $226 million compared to the $225.94 million average estimate based on five analysts. The reported number represents a change of -18.1% year over year.
- Adjusted Operating Income- Connected Technology Solutions: $12 million versus $16.97 million estimated by two analysts on average.
- Adjusted Operating Income- Wellspect Healthcare: $25 million versus the two-analyst average estimate of $26.14 million.
- Adjusted Operating Income- Orthodontic and Implant Solutions: $45 million versus the two-analyst average estimate of $16.63 million.
- Adjusted Operating Income- Essential Dental Solutions: $151 million versus the two-analyst average estimate of $126.53 million.
View all Key Company Metrics for Dentsply here>>>
Shares of Dentsply have returned -17.4% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
